不适合移植的大 B 细胞淋巴瘤二线使用 axicabtagene ciloleucel:ALYCANTE 最终分析
Second-line axicabtagene ciloleucel in large B-cell lymphoma ineligible for transplantation: ALYCANTE final analysis.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Comparative analysis of the tumor microenvironment in primary CNS and testicular large B-cell lymphomas using digital image analysis and its implications for immunotherapy.
Comparative analysis of the tumor microenvironment in primary CNS and testicular large B-cell lymphomas using digital image analysis and its implications for immunotherapy.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
免疫豁免部位的原发性大B细胞淋巴瘤,包括原发性中枢神经系统淋巴瘤(PCNSL)和原发性睾丸淋巴瘤(PTL),表现出独特的临床病理特征,导致其侵袭性行为和免疫逃逸。虽然PCNSL和PTL的分子特征已被广泛研究,但肿瘤微环境(TME)仍未被充分了解。特别是,尚无研究直接比较PCNSL和PTL的TME,这凸显了理解其免疫生物学方面的关键空白。
我们使用基于深度学习的数字图像分析对55例累及中枢神经系统(CNS)和睾丸的弥漫性大B细胞淋巴瘤病例进行了分析。对关键免疫标志物进行了免疫组化染色,包括CD3、CD4、CD8、FOXP3、PD-1、TIM-3、CD68和CD163,以表征TME组成。与PCNSL相比,PTL表现出显著更高水平的TIL(肿瘤浸润淋巴细胞),包括CD3+和CD8+T细胞(P < 0.001)。PTL中T细胞耗竭指数显著较低(P < 0.001),而CD163+巨噬细胞在PCNSL中更为占优势,提示CNS中TME更具免疫抑制作用。TME因子的相关性分析揭示了CNS与睾丸之间的差异,PCNSL中免疫标志物之间的相互关系更强。
我们的发现凸显了PCNSL与PTL之间不同的TME特征。PCNSL中CD163+巨噬细胞占优势和更高的T细胞耗竭提示巨噬细胞靶向治疗可能获益。相比之下,TME更为活跃的PTL可能对免疫检查点阻断更具应答性。
本研究为免疫豁免部位原发性大B细胞淋巴瘤的免疫景观提供了新的见解,强调需要针对部位特异性的治疗方法。
Primary large B-cell lymphomas of immune-privileged sites, including primary central nervous system lymphoma (PCNSL) and primary testicular lymphoma (PTL), exhibit distinct clinicopathologic features contributing to aggressive behavior and immune evasion. While the molecular characteristics of PCNSL and PTL have been extensively studied, the tumor microenvironment (TME) remains insufficiently understood. In particular, no study has directly compared the TME of PCNSL and PTL, highlighting a critical gap in understanding their immunobiology.
We analyzed 55 cases of diffuse large B-cell lymphoma involving the central nervous system (CNS) and testis using deep learning-based digital image analysis. Immunohistochemical staining was performed for key immune markers, including CD3, CD4, CD8, FOXP3, PD-1, TIM-3, CD68, and CD163, to characterize TME composition. PTL exhibited significantly higher levels of tumor-infiltrating lymphocytes, including CD3 + and CD8 + T-cells, compared to PCNSL (P < 0.
001). The T-cell exhaustion index was significantly lower in PTL (P < 0. 001), while CD163 + macrophages were more predominant in PCNSL, suggesting a more immunosuppressive TME in the CNS. Correlation analyses of TME factors revealed differences between the CNS and testis, with stronger interrelationships among immune markers in PCNSL.
Our findings highlight distinct TME characteristics between PCNSL and PTL. The predominance of CD163 + macrophages and higher T-cell exhaustion in PCNSL suggests potential benefits of macrophage-targeted therapies. In contrast, PTL, with a more active TME, may be more responsive to immune checkpoint blockade.
This study provides novel insights into the immune landscape of primary large B-cell lymphomas of immune-privileged sites, emphasizing the need for site-specific treatment approaches.
MEMBER ACCOUNT
登录成功会直接打开下一页。